Cleared Traditional

K130393 - MIRADA RTX

K130393 is an FDA 510(k) clearance for MIRADA RTX, manufactured by Mirada Medical, Ltd.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 33-day FDA review.

K130393 · Mirada Medical, Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2013
Decision
33d
Days
Class 2
Risk

K130393 is an FDA 510(k) clearance for the MIRADA RTX. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Mirada Medical, Ltd. (Oxford, GB). The FDA issued a Cleared decision on March 20, 2013 after a review of 33 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Mirada Medical, Ltd. devices

FDA 510(k) Submission Details - K130393

510(k) Number K130393 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 15, 2013
Decision Date March 20, 2013
Days to Decision 33 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
74d faster than avg
Panel avg: 107d · This submission: 33d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2182
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K130393.
5MP MONOCHROME LCD MONITOR, RADIFORCE GX540
K130336 · Eizo Nanao Corporation · Mar 2013
NOBELCLINICIAN
K123976 · Nobel Biocare AB · Mar 2013
SUITEHEART
K130228 · Neosoft, LLC · Mar 2013
RESOLUTIONMD MOBILE 3.1 MODEL RMD-MOB-31
K123186 · Calgary Scientific, Inc. · Mar 2013
STEREOS WORKSTATION
K130395 · Eos Imaging, Inc. · Mar 2013
MEDICVOD, MEDICAST, MEDISHOW, MEDISEARCH, CENTRAL STORAGE SYSTEM - CSS
K123426 · Orpheus Medical , Ltd. · Mar 2013